-
1
-
-
0038476135
-
Treatment of slow-channel congenital myasthenic syndrome with fluoxetine
-
Harper C.M., Fukodome T., and Engel A.G. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60 (2003) 1710-1713
-
(2003)
Neurology
, vol.60
, pp. 1710-1713
-
-
Harper, C.M.1
Fukodome, T.2
Engel, A.G.3
-
2
-
-
33646585179
-
Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine
-
Colomer J., Muller J.S., Vernet A., Nascimento A., Pons M., Gonzalez V., Abicht A., and Lochmuller H. Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine. Neuromuscul. Disord. 16 (2006) 329-333
-
(2006)
Neuromuscul. Disord.
, vol.16
, pp. 329-333
-
-
Colomer, J.1
Muller, J.S.2
Vernet, A.3
Nascimento, A.4
Pons, M.5
Gonzalez, V.6
Abicht, A.7
Lochmuller, H.8
-
3
-
-
0034119973
-
Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase
-
Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D., Taylor P., Hinrichs S.H., and Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293 (2000) 896-902
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.293
, pp. 896-902
-
-
Xie, W.1
Stribley, J.A.2
Chatonnet, A.3
Wilder, P.J.4
Rizzino, A.5
McComb, R.D.6
Taylor, P.7
Hinrichs, S.H.8
Lockridge, O.9
-
4
-
-
12244284582
-
Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions
-
Minic J., Chatonnet A., Krejci E., and Molgo J. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions. Br. J. Pharmacol. 138 (2003) 177-187
-
(2003)
Br. J. Pharmacol.
, vol.138
, pp. 177-187
-
-
Minic, J.1
Chatonnet, A.2
Krejci, E.3
Molgo, J.4
-
5
-
-
4243100595
-
Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice
-
Adler M., Manley H.A., Purcell A.L., Deshpande S.S., Hamilton T.A., Kan R.K., Oyler G., Lockridge O., Duysen E.G., and Sheridan R.E. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve. 30 (2004) 317-327
-
(2004)
Muscle Nerve.
, vol.30
, pp. 317-327
-
-
Adler, M.1
Manley, H.A.2
Purcell, A.L.3
Deshpande, S.S.4
Hamilton, T.A.5
Kan, R.K.6
Oyler, G.7
Lockridge, O.8
Duysen, E.G.9
Sheridan, R.E.10
-
6
-
-
28744442436
-
Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance
-
Girard E., Barbier J., Chatonnet A., Krejci E., and Molgo J. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance. Chem. Biol. Interact. 157 (2005) 87-96
-
(2005)
Chem. Biol. Interact.
, vol.157
, pp. 87-96
-
-
Girard, E.1
Barbier, J.2
Chatonnet, A.3
Krejci, E.4
Molgo, J.5
-
7
-
-
34249650103
-
Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice
-
Girard E., Bernard V., Minic J., Chatonnet A., Krejci E., and Molgo J. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Life Sci. 80 (2007) 2380-2385
-
(2007)
Life Sci.
, vol.80
, pp. 2380-2385
-
-
Girard, E.1
Bernard, V.2
Minic, J.3
Chatonnet, A.4
Krejci, E.5
Molgo, J.6
-
8
-
-
0037199344
-
Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse
-
Duysen E.G., Stribley J.A., Fry D.L., Hinrichs S.H., and Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res. Dev. Brain. Res. 137 (2002) 43-54
-
(2002)
Brain Res. Dev. Brain. Res.
, vol.137
, pp. 43-54
-
-
Duysen, E.G.1
Stribley, J.A.2
Fry, D.L.3
Hinrichs, S.H.4
Lockridge, O.5
-
9
-
-
33745004603
-
Outcome of acetylcholinesterase deficiency for neuromuscular functioning
-
Mouisel E., Blondet B., Escourrou P., Chatonnet A., Molgo J., and Ferry A. Outcome of acetylcholinesterase deficiency for neuromuscular functioning. Neurosci. Res. 55 (2006) 389-396
-
(2006)
Neurosci. Res.
, vol.55
, pp. 389-396
-
-
Mouisel, E.1
Blondet, B.2
Escourrou, P.3
Chatonnet, A.4
Molgo, J.5
Ferry, A.6
-
10
-
-
33751078591
-
The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine
-
Lenkey N., Karoly R., Kiss J.P., Szasz B.K., Vizi E.S., and Mike A. The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. Mol. Pharmacol. 70 (2006) 2052-2063
-
(2006)
Mol. Pharmacol.
, vol.70
, pp. 2052-2063
-
-
Lenkey, N.1
Karoly, R.2
Kiss, J.P.3
Szasz, B.K.4
Vizi, E.S.5
Mike, A.6
-
11
-
-
33750480200
-
Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine
-
Rajamani S., Eckhardt L.L., Valdivia C.R., Klemens C.A., Gillman B.M., Anderson C.L., Holzem K.M., Delisle B.P., Anson B.D., Makielski J.C., and January C.T. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br. J. Pharmacol. 149 (2006) 481-489
-
(2006)
Br. J. Pharmacol.
, vol.149
, pp. 481-489
-
-
Rajamani, S.1
Eckhardt, L.L.2
Valdivia, C.R.3
Klemens, C.A.4
Gillman, B.M.5
Anderson, C.L.6
Holzem, K.M.7
Delisle, B.P.8
Anson, B.D.9
Makielski, J.C.10
January, C.T.11
-
12
-
-
33745159710
-
T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine
-
Traboulsie A., Chemin J., Kupfer E., Nargeot J., and Lory P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol. Pharmacol. 69 (2006) 1963-1968
-
(2006)
Mol. Pharmacol.
, vol.69
, pp. 1963-1968
-
-
Traboulsie, A.1
Chemin, J.2
Kupfer, E.3
Nargeot, J.4
Lory, P.5
|